For the latest
cancer COVID-19 resources, click on this link
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Brain & nervous system
Sign up for latest coverage
Submit your event
cancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Prevention & screening
Middle East and North Africa
Central America and the Caribbean
Australia and Oceania
27 May - 1 Jun 2020
Chicago, United States of America
ASCO 2020: UK-first study shows feasibility of genetic screening for prostate cancer
ASCO 2020: Blood test predicts response to prostate cancer treatment
ASCO 2020: Adoptive T-cell therapy ADP-A2M4 targeting MAGE-A4 shows early activity in patients with ...
ASCO 2020: Trastuzumab combined with trimodality treatment does not improve outcomes for patients
ASCO 2020: Combined cediranib and olaparib presents similar activity to standard of care treatment
ASCO 2020: Targeted therapy tepotinib for non-small cell lung cancer with MET exon 14 skipping mutat...
ASCO 2020: Trastuzumab achieves slight reduction in recurrence for women with HER2-positive DCIS
ASC0 2020: Study reveals factors influencing outcomes in kidney cancer treated with immunotherapy
ASCO 2020: Targeted therapy pralsetinib achieves high response rates in advanced cancers with RET ge...
ASCO 2020: Researchers underscore efficacy of pembrolizumab plus axitinib in treating advanced renal...
ASCO 2020: Combination therapy well-tolerated and highly effective for patients with IDH1-mutated AM...
ASCO 2020: Pembrolizumab doubles time to disease progression in patients with advanced colorectal ca...
ASCO 2020: Post-surgery osimertinib delays disease recurrence in patients with localised non-small c...
ASCO 2020: Multinational consortium reports COVID-19 impact on cancer patients
ASCO 2020: Immunotherapy avelumab shows potential in rare gynaecological cancer resistant to chemoth...
ASCO 2020: Surgery and radiation do not extend survival in newly diagnosed metastatic breast cancer
ASCO 2020: Immunotherapy following chemotherapy offers extended survival to patients with advanced u...
ASCO 2020: Chemo within 3 months of COVID-19 diagnosis associated with an increased risk of death in...
ASCO 2020: Large scale precision medicine approach successfully applied to paediatric cancers with p...
ASCO 2020: Special report provides guidance to oncology practices on resuming cancer care during COV...
ASCO 2020: Early data show cancer progression associated with increased risk of death in patients wi...
ASCO 2020: Pembrolizumab plus chemotherapy demonstrated improvement in PFS for patients with metasta...
ASCO 2020: Durvalumab added to standard chemotherapy improved overall survival in mesothelioma
ASCO 2020: Trial confirms durable and long-term survival benefit for nivolumab plus ipilimumab over ...
ASCO 2020: Apalutamide significantly improved overall survival in patients with non-metastatic castr...
ASCO 2020: Video conference intervention significantly reduces anxiety and distress among remote car...
ASCO 2020: Maintenance therapy With PARP inhibitor olaparib extends survival by over 1 year in patie...